Table 1.
Demographic and clinical characteristics of patients
| Characteristic | All patients (n=702) | First treatment (n=659) | Retreatment (n=43) | p-value |
|---|---|---|---|---|
| Median age with range (years) | 35 (19–80) | 34 (19–80) | 37 (20–71) | NS |
| Female | 219 (31.2%) | 203 (30.8%) | 16 (37%) | NS |
| Smear positive | 244 (34.8%) | 222 (33.7%) | 22 (51%) | 0.02 |
| Pulmonary TB | 614 (87.5%) | 579 (87.9%) | 35 (81%) | NS |
| Extrapulmonary TB | 88 (12.5%) | 80 (12.1%) | 8 (19%) | NS |
| Meningitis (% EPTB) | 1 (1%) | 1 (1%) | 0 | NS |
| Lymphadenitis (% EPTB) | 17 (19%) | 16 (20%) | 1 (13%) | NS |
| Pericarditis (% EPTB) | 10 (11%) | 8 (10%) | 2 (25%) | NS |
| Pleuritis (% EPTB) | 54 (61%) | 49 (61%) | 5 (63%) | NS |
| Arthritis (% EPTB) | 1 (1%) | 1 (1%) | 0 | NS |
| Spinal (% EPTB) | 2 (2%) | 2 (3%) | 0 | NS |
| Miliarya (% EPTB) | 8 (9%) | 8 (10%) | 0 | NS |
| Abnormal CXRb | 415 (59.1%) | 392 (59.5%) | 23 (53%) | NS |
| Unilateral infiltrate (% Abnormal CXR) | 156 (37.6%) | 151 (38.5%) | 5 (22%) | NS |
| Bilateral infiltrate (% Abnormal CXR) | 201 (48.4%) | 188 (48.0%) | 13 (57%) | NS |
| Adenopathy (% Abnormal CXR) | 69 (16.6%) | 68 (17.3%) | 1 (4%) | NS |
| Miliary (% Abnormal CXR) | 31 (7.5%) | 30 (7.7%) | 1 (4%) | NS |
| Cavitary lesion (% Abnormal CXR) | 96 (23.1%) | 92 (23.5%) | 4 (17%) | NS |
| Pleural effusion (% Abnormal CXR) | 68 (16.4%) | 61 (15.6%) | 7 (30%) | NS |
| Pericardial effusion (% Abnormal CXR) | 11 (2.7%) | 10 (2.6%) | 1 (4%) | NS |
| HIV positive | 420 (59.8%) | 393 (59.6%) | 27 (63%) | NS |
| On ART (% of HIV+) | 137 (32.6%) | 121 (30.8%) | 16 (59%) | <0.001 |
| Median CD4 Count among positives (IQR) | 167 (81–293) | 160 (76–292) | 185 (86–253) | NS |
| VL suppressed to <400 (% of HIV+on ART) (n=53 VLs) | 38 (72%) | 33 (75%) | 5 (56%) | NS |
ART: antiretroviral therapy; CXR: chest X-ray; EPTB: extrapulmonary TB; NS: not significant; VL: viral load.
a More than one Extrapulmonary category; b Total sums to >100% because patients often had more than one finding on CXR.